integer holdings corp. - ITGR
ITGR
Close Chg Chg %
77.73 0.98 1.26%
Closed Market
78.71
+0.98 (1.26%)
Volume: 222.02K
Last Updated:
Dec 24, 2025, 12:59 PM EDT
Company Overview: integer holdings corp. - ITGR
ITGR Key Data
| Open $77.88 | Day Range 77.66 - 79.23 |
| 52 Week Range 62.10 - 146.36 | Market Cap $2.72B |
| Shares Outstanding 35.04M | Public Float 34.39M |
| Beta 0.81 | Rev. Per Employee N/A |
| P/E Ratio 32.95 | EPS $2.49 |
| Yield 0.00% | Dividend $3.33 |
| EX-DIVIDEND DATE Mar 14, 2016 | SHORT INTEREST N/A |
| AVERAGE VOLUME 619.05K |
ITGR Performance
| 1 Week | 0.17% | ||
| 1 Month | 9.05% | ||
| 3 Months | -22.45% | ||
| 1 Year | -41.59% | ||
| 5 Years | -3.57% |
ITGR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
About integer holdings corp. - ITGR
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The firm has the following product lines: Cardio and Vascular, Cardiac Rhythm Management and Neuromodulation, and Other Markets. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
ITGR At a Glance
Integer Holdings Corp.
5830 Granite Parkway
Plano, Texas 75024
| Phone | 1-214-618-5243 | Revenue | 1.72B | |
| Industry | Medical Specialties | Net Income | 120.72M | |
| Sector | Health Technology | 2024 Sales Growth | 7.698% | |
| Fiscal Year-end | 12 / 2025 | Employees | 11,000 | |
| View SEC Filings |
ITGR Valuation
| P/E Current | 33.171 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 39.134 |
| Price to Sales Ratio | 2.747 |
| Price to Book Ratio | 2.746 |
| Price to Cash Flow Ratio | 23.02 |
| Enterprise Value to EBITDA | 17.024 |
| Enterprise Value to Sales | 3.364 |
| Total Debt to Enterprise Value | 0.191 |
ITGR Efficiency
| Revenue/Employee | 156,349.909 |
| Income Per Employee | 10,974.364 |
| Receivables Turnover | 4.927 |
| Total Asset Turnover | 0.571 |
ITGR Liquidity
| Current Ratio | 2.954 |
| Quick Ratio | 1.866 |
| Cash Ratio | 0.205 |
ITGR Profitability
| Gross Margin | 24.739 |
| Operating Margin | 13.53 |
| Pretax Margin | 8.58 |
| Net Margin | 7.019 |
| Return on Assets | 4.021 |
| Return on Equity | 7.715 |
| Return on Total Capital | 4.44 |
| Return on Invested Capital | 4.601 |
ITGR Capital Structure
| Total Debt to Total Equity | 68.384 |
| Total Debt to Total Capital | 40.612 |
| Total Debt to Total Assets | 35.974 |
| Long-Term Debt to Equity | 66.799 |
| Long-Term Debt to Total Capital | 39.671 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Integer Holdings Corp. - ITGR
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.22B | 1.38B | 1.60B | 1.72B | |
Sales Growth
| +13.88% | +12.80% | +15.87% | +7.70% | |
Cost of Goods Sold (COGS) incl D&A
| 914.05M | 1.05B | 1.24B | 1.29B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 89.60M | 101.84M | 98.84M | 107.13M | |
Depreciation
| 48.01M | 53.53M | 45.67M | 52.52M | |
Amortization of Intangibles
| 41.60M | 48.31M | 53.17M | 54.61M | |
COGS Growth
| +12.49% | +15.08% | +17.61% | +4.62% | |
Gross Income
| 307.70M | 326.26M | 359.75M | 425.48M | |
Gross Income Growth
| +18.21% | +6.03% | +10.26% | +18.27% | |
Gross Profit Margin
| +25.19% | +23.67% | +22.53% | +24.74% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 164.90M | 188.88M | 186.22M | 193.87M | |
Research & Development
| 51.98M | 60.92M | 63.77M | 50.44M | |
Other SG&A
| 112.91M | 127.97M | 122.45M | 143.43M | |
SGA Growth
| +4.83% | +14.55% | -1.41% | +4.11% | |
Other Operating Expense
| 577.00K | 1.57M | 2.09M | (1.08M) | |
Unusual Expense
| 11.06M | 15.11M | 18.93M | 23.27M | |
EBIT after Unusual Expense
| 131.16M | 120.70M | 152.51M | 209.42M | |
Non Operating Income/Expense
| (5.51M) | (7.14M) | 5.16M | (5.48M) | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| (3.06M) | (7.64M) | (481.00K) | (533.00K) | |
Interest Expense
| 24.59M | 37.60M | 50.37M | 56.37M | |
Interest Expense Growth
| -28.14% | +52.90% | +33.97% | +11.91% | |
Gross Interest Expense
| 24.59M | 37.60M | 50.37M | 56.37M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 101.06M | 75.96M | 107.29M | 147.56M | |
Pretax Income Growth
| +17.23% | -24.84% | +41.25% | +37.53% | |
Pretax Margin
| +8.27% | +5.51% | +6.72% | +8.58% | |
Income Tax
| 8.04M | 10.61M | 16.64M | 26.51M | |
Income Tax - Current - Domestic
| 11.06M | 21.23M | 12.99M | 19.96M | |
Income Tax - Current - Foreign
| 8.46M | 6.87M | 13.14M | 19.48M | |
Income Tax - Deferred - Domestic
| (9.06M) | (16.27M) | (7.62M) | (9.70M) | |
Income Tax - Deferred - Foreign
| (2.42M) | (1.22M) | (1.87M) | (3.23M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| (3.06M) | (7.64M) | (481.00K) | (533.00K) | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 93.02M | 65.35M | 90.65M | 121.05M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 93.02M | 65.35M | 90.65M | 121.05M | |
Net Income Growth
| +20.40% | -29.75% | +38.71% | +33.54% | |
Net Margin Growth
| +7.61% | +4.74% | +5.68% | +7.04% | |
Extraordinaries & Discontinued Operations
| - | - | - | (335.00K) | - |
Discontinued Operations
| - | - | - | (335.00K) | - |
Net Income After Extraordinaries
| 93.02M | 65.35M | 90.65M | 120.72M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 93.02M | 65.35M | 90.65M | 120.72M | |
EPS (Basic)
| 2.8194 | 1.9727 | 2.7206 | 3.5927 | |
EPS (Basic) Growth
| +19.86% | -30.03% | +37.91% | +32.06% | |
Basic Shares Outstanding
| 32.99M | 33.13M | 33.32M | 33.60M | |
EPS (Diluted)
| 2.7969 | 1.9591 | 2.6853 | 3.3863 | |
EPS (Diluted) Growth
| +19.87% | -29.95% | +37.07% | +26.11% | |
Diluted Shares Outstanding
| 33.26M | 33.36M | 33.76M | 35.65M | |
EBITDA
| 231.83M | 237.65M | 270.28M | 339.82M | |
EBITDA Growth
| +24.96% | +2.51% | +13.73% | +25.73% | |
EBITDA Margin
| +18.98% | +17.24% | +16.92% | +19.76% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 84.286 | |
| Number of Ratings | 12 | Current Quarters Estimate | 1.698 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 6.338 | |
| Last Quarter’s Earnings | 1.79 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 5.30 | Next Fiscal Year Estimate | 6.296 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 8 | 6 | 9 | 9 |
| Mean Estimate | 1.70 | 1.35 | 6.34 | 6.30 |
| High Estimates | 1.74 | 1.47 | 6.38 | 6.42 |
| Low Estimate | 1.65 | 1.29 | 6.29 | 6.22 |
| Coefficient of Variance | 1.79 | 4.89 | 0.45 | 0.93 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 3 | 3 | 8 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 8 | 7 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Buy |
SEC Filings for Integer Holdings Corp. - ITGR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Integer Holdings Corp. - ITGR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 28, 2025 | Payman Khales President & CEO; Director | 7,543 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Joseph William Dziedzic President & CEO; Director | 327,986 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 14, 2025 | Joseph William Dziedzic President & CEO; Director | 314,591 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $120.14 per share | 37,794,962.74 |
| Mar 14, 2025 | Joseph William Dziedzic President & CEO; Director | 36,202 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 26, 2025 | Kirk Thor Chief Human Resources Officer | 29,011 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Margaret Carthy EVP, Qlty & Regulatory Affairs | 7,677 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Margaret Carthy EVP, Qlty & Regulatory Affairs | 9,787 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Andrew Senn SVP, Strategy and Business Dev | 10,633 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Payman Khales President, C&V | 19,738 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $129.87 per share | 2,563,374.06 |
| Feb 26, 2025 | Payman Khales President, C&V | 23,201 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Tom P. Thomas VP, Corporate Controller | 4,480 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $129.87 per share | 581,817.60 |
| Feb 26, 2025 | Tom P. Thomas VP, Corporate Controller | 5,130 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Tom P. Thomas VP, Corporate Controller | 4,190 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Kirk Thor Chief Human Resources Officer | 26,689 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $129.87 per share | 3,466,100.43 |
| Feb 26, 2025 | McAlister C. Marshall SVP, Gen Counsel & Secretary | 5,598 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Kirk Thor Chief Human Resources Officer | 24,875 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Diron Smith EVP, Chief Financial Officer | 5,225 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $129.87 per share | 678,570.75 |
| Feb 26, 2025 | Margaret Carthy EVP, Qlty & Regulatory Affairs | 7,686 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $129.87 per share | 998,180.82 |
| Feb 26, 2025 | Andrew Senn SVP, Strategy and Business Dev | 8,545 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | McAlister C. Marshall SVP, Gen Counsel & Secretary | 6,830 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $129.87 per share | 887,012.10 |